IRCT20240508061704N1Not yet recruitingPhase 1
Investigating the effectiveness of extracellular vesicles released from mesenchymal stem cells in thetreatment of patients with persistent vitiligo lesions: a pilot study
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Enrollment
- 6
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 50 years (—)
- Sex
- All
Inclusion Criteria
- •Patients should have stable vitiligo
- •The patient's medical history should report the stability of the patient's disease in terms of the absence of new lesions during the last one year
Exclusion Criteria
- •Patients with more than 20% of the body surface involved with vitiligo
- •pregnant women
- •lactating women
- •patients with skin cancer
- •patients who have undergone other treatments for vitiligo in the past 3 months
Investigators
Similar Trials
Completed
Not Applicable
Extracorporeal shock wave therapy (ESWT) and kinesiotherapy (KIN) on women with bilateral knee osteoarthritisknee painMusculoskeletal - OsteoarthritisPhysical Medicine / Rehabilitation - PhysiotherapyosteoarthritisACTRN12616000589482Holycross College60
Not yet recruiting
Phase 3
Study the effect of injection of plasma gel contained with skin fibroblasts in rejuvenatioIRCT20140911019125N5Kerman University of Medical Sciences20
Not yet recruiting
Not Applicable
The effect of external factor on the composition of intestinal microbiota after oral administration of microbiomeKCT0005826Jeonbuk National University Hospital30
Completed
Phase 2
Study the effects of lithotripsy in renal cyst formatioCondition 1: Renal Stone. Condition 2: Renal Cyst.Calculus of kidneyCyst of kidney, acquiredIRCT201607179904N2Vice Chancellor for research of Tabriz University of Medical Sciences60
Not yet recruiting
Phase 3
Effect of Nimbadi guggulu, Trivrutadi varti with Guduchyadi kwatha, Vatalodhra kwatha and Sukoshna jala vaginal wash in White vaginal discharge (Vulvovaginitis).CTRI/2024/03/064294ONE
